RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development
Press Releases
November 19, 2024

RiDYMO® Platform Drives New Breakthroughs in highly potent PLK1 Inhibitors Development

BEIJING, Nov. 19, 2024 /PRNewswire/ -- With the support of the RiDYMO® platform, we are able to comprehensively explore various potential targets in drug development, including protein-protein interactions, kinases, GPCRs,

bradford

The Bradford Era

Local & Social